News

Search

Sort by

RESEARCH NEWS
Target ALS Grantee NRG Therapeutics Advances NRG5051 into Phase I Clinical Trial

JANUARY 26, 2026
ANNOUNCEMENT
Letter From Our Founder: Reflecting on 2024 Target ALS Annual Meeting

JUNE 28, 2024
ANNOUNCEMENT
Identifying Novel Drug Targets: Expanding the Horizons of ALS Treatment

JUNE 28, 2024